Citations 424

Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7237-7238

10.1182/blood-2022-169533

Prognostic Value of Translocation 11;14 in Patients with Relapsed/Refractory Myeloma Receiving Anti-CD38 Therapy

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5223-5224

10.1182/blood-2022-165541

LP-118, a Novel BCL2 Inhibitor, Shows Potent in Vitro Anti-Myeloma Activity

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7129-7130

10.1182/blood-2022-167372

Pathogenic Germline Variants in a Prospective Multi-Center Cohort of Patients with Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7162-7163

10.1182/blood-2022-167940

Electrocardiogram As a Marker of Cardiac Response in Light Chain Amyloidosis

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12566-12567

10.1182/blood-2022-168083

Causes of Death Among Patients with Multiple Myeloma: A 10 Year Longitudinal Analysis of a Population-Based Cohort in Ontario, Canada

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 427-429

10.1182/blood-2022-157815

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10017-10019

10.1182/blood-2022-167181

A Single Next Generation Sequencing Assay for Detection of Driver Mutations, Translocations and Copy Number Alterations in Patients with Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7180-7181

10.1182/blood-2022-170749

Prognostic Value of Month 1 Bone Marrow and PET MRD Status in CAR-T Therapy for Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1862-1864

10.1182/blood-2022-166662

Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5212-5213

10.1182/blood-2022-165569